The 52-Week Low Club (SGP)(PAY)(DEEP)
Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58. Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23. Crocs (CROX) Downgrade by JP Morgan. Falls to…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58.
Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23.
Crocs (CROX) Downgrade by JP Morgan. Falls to $15.53 from 52-week high of $75.21.
Riverbed Technology (RVBD) No big, bad news. Stock down to $13.62 from 52-week high of $52.81.
Verifone (PAY) CFO is out after restatement. Shares drop to $12.65 from 52-week high of $50.
Schering-Plough (SGP) Fitch downgrades after negative comment on key drug product. Falls to $13.91 from 52-week high of $33.81.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.